parthenolide and Carcinoma, Epidermoid

parthenolide has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, WC; Chen, BK; Huang, CR; Ko, SC; Shieh, JM; Yang, JH1
Cole, JR; Hoffmann, JJ; Torrance, SJ; Widehopf, RM1

Other Studies

2 other study(ies) available for parthenolide and Carcinoma, Epidermoid

ArticleYear
Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Chromones; Cisplatin; Cytotoxins; DNA Primers; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1beta; Morpholines; NF-kappa B; Oncogene Protein v-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Signal Transduction

2013
Cytotoxic agents from Michelia champaca and Talauma ovata: parthenolide and costunolide.
    Journal of pharmaceutical sciences, 1977, Volume: 66, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Humans; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Sesquiterpenes

1977